Zynteglo

Bluebird sets $1.8M price tag for blood-disease gene therapy
Biopharma Dive
Fri, 06/14/19 - 12:08 pm
drug pricing
Bluebird Bio
Zynteglo
Europe
beta thalassemia
Patients, payers await pricing plans for bluebird's first approved gene therapy
BioCentury
Tue, 06/4/19 - 11:04 am
Bluebird Bio
gene therapy
Zynteglo
drug pricing
beta thalassemia
Bluebird Bio’s Gene Therapy for Blood Disease Wins European Approval
Xconomy
Mon, 06/3/19 - 07:50 pm
Bluebird Bio
gene therapy
Europe
Zynteglo
EMA
beta thalassemia
Bluebird's not looking to break speed records with its first gene therapy launch
Fierce Pharma
Fri, 05/10/19 - 12:48 pm
Bluebird Bio
gene therapy
beta thalassemia
Zynteglo
drug launches
bluebird to rollout Zynteglo starting in Germany next half
BioCentury
Thu, 05/9/19 - 11:09 pm
Bluebird Bio
beta thalassemia
Germany
Zynteglo

Pages